Breaktrhough Terapy in USA for Novartis’s Promacta, blood disorder treatment
Novartis could soon offer SAA patients new treatment, as it on Thursday announced getting the Breakthrough Therapy for its Promacta…
Pharmaceuticals, Biotechnology and Life Sciences
Novartis could soon offer SAA patients new treatment, as it on Thursday announced getting the Breakthrough Therapy for its Promacta…
Mereo BioPharma Group has finished £10 million tranche of the credit loan set up in August 2017 with Silicon Valley…
Alergan will have to cut over 1000 jobs from commercial and other functions, the company said on Wednesday.
The FDA has announced more steps to encourage generic competition as part of its three-components Drug Competition Action Plan, by which…
Boehringer Ingelheim today announced an increase in funding for its corporate venture fund, known as the Boehringer Ingelheim Venture Fund (BIVF), from EUR 100 to 250 million.
While physically over-the-counter (OTC) medicine packaging may mirror the prescription drug market, with continued strong demand for plastic primary pharmaceutical…
Novartis on Wednesday sadi that Kisqali has gotten US Food and Drug Administration (FDA) Breakthrough Therapy designation for initial endocrine-based…
Scientists have found a new way to explain the hearing loss caused by cisplatin, a powerful drug used to treat…
The U.S. Food and Drug Administration has approved Spark Therapeutics’s Luxturna (voretigene neparvovec-rzyl), a new gene therapy, to treat children and adult…
U.S. Food and Drug Administration (FDA) has approved the Portola Pharmaceuticals’s Prior Approval Supplement (PAS) for Bevyxxa (betrixaban) ahead of…